ArticleEndocrine-related cancer2019

Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC.

Adwitiya Kar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.